Mesoblast Limited Included In Standard And Poor/ASX 200 Index
Melbourne, April 18, 2011 (ABN Newswire) - Standard and Poor's (S&P) Indices has announced that regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) will be included in the S&P/ASX 200 Index, effective after the close of business on Wednesday 27 April, 2011.